Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2010, Article ID 173652, 6 pages
http://dx.doi.org/10.1155/2010/173652
Methodology Report

Comparison of Measurements of Autoantibodies to Glutamic Acid Decarboxylase and Islet Antigen-2 in Whole Blood Eluates from Dried Blood Spots Using the RSR-Enzyme Linked Immunosorbent Assay Kits and In-House Radioimmunoassays

1Unit for Diabetes and Celiac Disease, Department of Clinical Sciences, Lund University, Wallenberg Laboratory, Entrance 46, University Hospital MAS, 205 02 Malmö, Sweden
2Department of Clinical Chemistry, University Hospital MAS, 205 02 Malmö, Sweden
3Unit for Diabetes and Celiac Disease, Department of Clinical Sciences, Lund University, Clinical Research Center (CRC), University Hospital MAS, 205 02 Malmö, Sweden

Received 26 June 2009; Revised 7 September 2009; Accepted 24 March 2010

Academic Editor: Rodica Pop-Busui

Copyright © 2010 Anders Persson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-O. Jeppsson, P. Jerntorp, L.-O. Almer, R. Persson, G. Ekberg, and G. Sundkvist, “Capillary blood on filter paper for determination of HbA1c by ion exchange chromatography,” Diabetes Care, vol. 19, no. 2, pp. 142–145, 1996. View at Google Scholar · View at Scopus
  2. S. Vallian and H. Moeini, “A quantitative bacterial micro-assay for rapid detection of serum phenylalanine in dry blood-spots: application in phenylketonuria screening,” Journal of Applied Genetics, vol. 47, no. 1, pp. 79–83, 2006. View at Google Scholar · View at Scopus
  3. A. S. Youngpairoj, A. S. Masciotra, C. Garrido, N. Zahonero, C. de Mendoza, and J. G. Garcia-Lerma, “HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4C,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 6, pp. 1217–1220, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Stevens, G. Sherman, R. Downing et al., “Role of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosis,” The Open AIDS Journal, vol. 2, pp. 17–25, 2008. View at Google Scholar
  5. S. Tanner and T. W. McDade, “Enzyme immunoassay for total immunoglobulin E in dried blood spots,” American Journal of Human Biology, vol. 19, no. 3, pp. 440–442, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. C. De Castro, L. G. Borges, R. D. S. De Souza, M. Grudzinski, and P. A. D'Azevedo, “Evaluation of the human immunodeficiency virus type 1 and 2 antibodies detection in dried whole blood spots (DBS) samples,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 50, no. 3, pp. 151–156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Alm and A. Larsson, “Evaluation of a nation-wide neonatal metabolic screening programme in Sweden 1965–1979,” Acta Paediatrica Scandinavica, vol. 70, no. 5, pp. 601–607, 1981. View at Google Scholar · View at Scopus
  8. E. Carreiro-Lewandowski, “Newborn screening: an overview,” Clinical Laboratory Science, vol. 15, no. 4, pp. 229–238, 2002. View at Google Scholar · View at Scopus
  9. B. Wilcken and V. Wiley, “Newborn screening,” Pathology, vol. 40, no. 2, pp. 104–115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. W. A. Hagopian, Å. Lernmark, M. J. Rewers et al., “TEDDY—the environmental determinants of diabetes in the young: an observational clinical trial,” Annals of the New York Academy of Sciences, vol. 1079, pp. 320–326, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-Y. Xu, K. Pettersson, K. Blomberg, I. Hemmila, H. Mikola, and T. Lovgren, “Simultaneous quadruple-label fluorometric immunoassay of thyroid-stimulating hormone, 17α-hydroxyprogesterone, immunoreactive trypsin, and creatine kinase MM isoenzyme in dried blood spots,” Clinical Chemistry, vol. 38, no. 10, pp. 2038–2043, 1992. View at Google Scholar · View at Scopus
  12. J. M. Wenzlau, K. Juhl, L. Yu et al., “The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17040–17045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. C. F. Verge, D. Stenger, E. Bonifacio et al., “Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes. Combinatorial islet autoantibody workshop,” Diabetes, vol. 47, no. 12, pp. 1857–1866, 1998. View at Google Scholar · View at Scopus
  14. P. J. Bingley, E. Bonifacio, and P. W. Mueller, “Diabetes antibody standardization program: first assay proficiency evaluation,” Diabetes, vol. 52, no. 5, pp. 1128–1136, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Törn, P. W. Mueller, M. Schlosser, E. Bonifacio, and P. J. Bingley, “Diabetes antibody standardization program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2,” Diabetologia, vol. 51, no. 5, pp. 846–852, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Nilson, B. Ekholm, B. Rees Smith, C. Törn, and M. Hillman, “Calcium addition to EDTA plasma eliminates falsely positive results in the RSR GADAb ELISA,” Clinica Chimica Acta, vol. 388, no. 1-2, pp. 130–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Rahmati, Å. Lernmark, C. Becker et al., “A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits,” Clinical Laboratory, vol. 54, no. 7-8, pp. 227–235, 2008. View at Google Scholar · View at Scopus
  18. E. Bazzigaluppi, R. Bonfanti, P. J. Bingley, E. Bosi, and E. Bonifacio, “Capillary whole blood measurement of islet autoantibodies,” Diabetes Care, vol. 22, no. 2, pp. 275–279, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Wasserfall, M. Atkinson, E. Jodoin et al., “Glutamic acid decarboxylase and IA-2 autoantibodies in type 1 diabetes: comparing sample substrates for autoantibody determinations,” Pediatric Diabetes, vol. 1, no. 1, pp. 10–16, 2000. View at Google Scholar
  20. K. F. Lynch, B. Lernmark, J. Merlo, C. M. Cilio, S.-A. Ivarsson, and Å. Lernmark, “Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype,” Journal of Perinatology, vol. 28, no. 3, pp. 211–217, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. R. Mire-Sluis, R. Gaines Das, and Å. Lernmark, “The World Health Organization international collaborative study for islet cell antibodies,” Diabetologia, vol. 43, no. 10, pp. 1282–1292, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Landin Olsson, G. Sundkvist, and A. Lernmark, “Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus,” Diabetologia, vol. 30, no. 5, pp. 327–332, 1987. View at Google Scholar · View at Scopus
  23. P. G. Colman, U. Di Mario, A. Rabizadeh, F. Dotta, E. Anastasi, and G. S. Eisenbarth, “A prozone phenomenon interferes in islet cell antibody detection: direct comparison of two methods in subjects at risk of diabetes and in insulin dependent diabetics at onset,” Journal of Autoimmunity, vol. 1, no. 2, pp. 109–117, 1988. View at Google Scholar · View at Scopus
  24. G. Sundkvist, W. A. Hagopian, M. Landin-Olsson et al., “Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 78, no. 5, pp. 1159–1165, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. R. S. Schmidli, H. J. DeAizpurua, L. C. Harrison, and P. G. Colman, “Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile,” Journal of Autoimmunity, vol. 7, no. 1, pp. 55–66, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Z. Zimmet, R. B. Elliot, I. R. Mackay et al., “Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender,” Diabetic Medicine, vol. 11, no. 9, pp. 866–871, 1994. View at Google Scholar · View at Scopus
  27. C. Nilsson, D. Ursing, C. Törn, A. Åberg, and M. Landin-Olsson, “Presence of GAD antibodies during gestational diabetes mellitus predicts type 1 diabetes,” Diabetes Care, vol. 30, no. 8, pp. 1968–1971, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. I. Hawa, D. Fava, F. Medici et al., “Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality,” Diabetes Care, vol. 23, no. 2, pp. 228–233, 2000. View at Google Scholar · View at Scopus
  29. M. Raux, L. Finkielsztejn, D. Salmon-Ceron et al., “Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients,” Journal of Immunological Methods, vol. 222, no. 1-2, pp. 111–124, 1999. View at Publisher · View at Google Scholar · View at Scopus